Press Releases

All Releases
May 26, 2015
AngioDynamics to Present at the Jefferies 2015 Healthcare Conference
ALBANY, N.Y. , May 26, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Mark Frost , Executive Vice President and Chief Financial
May 11, 2015
AngioDynamics to Present at the UBS Global Healthcare Conference
ALBANY, N.Y. , May 11, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Joseph M. DeVivo , President and Chief Executive Officer, is
Apr 09, 2015
AngioDynamics Reports 2015 Third Quarter Financial Results
Third quarter fiscal 2015 net sales of $86.6 million ; flat vs. prior year, excluding the wind down of supply agreement and $1 million on a constant currency basis GAAP loss of $0.12 per share primarily due to one-time non-cash charges Non-GAAP adjusted net income of $0.12 per share, negatively
Mar 26, 2015
AngioDynamics to Report Fiscal 2015 Third Quarter Financial Results
ALBANY, N.Y. , March 26, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2015 third
Feb 25, 2015
AngioDynamics to Present at the Barclays Global Healthcare Conference
ALBANY, N.Y. , Feb. 25, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Joseph M. DeVivo , President and Chief Executive Officer,
Jan 08, 2015
AngioDynamics Reports 2015 Second Quarter Financial Results
Second Quarter Fiscal 2015 Net Sales increased 4% to $92.1 million ; 5% sales growth excluding supply agreement GAAP EPS of $0.04 ; Non-GAAP adjusted net income of $0.17 per share, a 21% YOY increase EBITDA of $11.9 million ; Adjusted EBITDA of $15.9 million , a 18% YOY increase Company raises
Dec 17, 2014
AngioDynamics to Report Fiscal 2015 Second Quarter Financial Results
ALBANY, N.Y. , Dec. 17, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2015 second
Dec 09, 2014
AngioDynamics Awarded HealthTrust PICC Contract
ALBANY, N.Y. , Dec. 9, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it signed an agreement with HealthTrust covering PICC
Nov 11, 2014
AngioDynamics to Present at Upcoming Investor Conferences
ALBANY, N.Y. , Nov. 11, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today the company will present at the following investor conferences
Displaying 101 - 120 of 649